Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

REDDY-SITAGLIPTIN DIN 02536803

Status: Approved
Holder: DR REDDY'S LABORATORIES LTD
Molecule: SITAGLIPTIN (SITAGLIPTIN PHOSPHATE)

Health Canada record

Active ingredient(s)SITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 100 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCA10BH01 SITAGLIPTIN
Original market date
Current status date31-Mar-2023
SourceHealth Canada DPD

Establishment licence of the holder

Dr Reddy's Laboratories (UK) Limited — licence , not currently licensed, last inspection rating C (2019-02-12).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing SITAGLIPTIN (SITAGLIPTIN PHOSPHATE)

DINProductCompanyFormStrengthStatus
02512475ACH-SITAGLIPTINACCORD HEALTHCARE INCTabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 25 MGMarketed
02512483ACH-SITAGLIPTINACCORD HEALTHCARE INCTabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 50 MGMarketed
02512491ACH-SITAGLIPTINACCORD HEALTHCARE INCTabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 100 MGMarketed
02543133BIO-SITAGLIPTINBIOMED PHARMATabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 100 MGApproved
02543117BIO-SITAGLIPTINBIOMED PHARMATabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 25 MGApproved
02543125BIO-SITAGLIPTINBIOMED PHARMATabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 50 MGApproved
02553937MINT-SITAGLIPTINMINT PHARMACEUTICALS INCTabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 100 MGMarketed
02553929MINT-SITAGLIPTINMINT PHARMACEUTICALS INCTabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 50 MGMarketed
02553910MINT-SITAGLIPTINMINT PHARMACEUTICALS INCTabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 25 MGMarketed
02558874MINT-SITAGLIPTIN/METFORMINMINT PHARMACEUTICALS INCTabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MGApproved
02558882MINT-SITAGLIPTIN/METFORMINMINT PHARMACEUTICALS INCTabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 50 MG; METFORMIN HYDROCHLORIDE 850 MGApproved
02558890MINT-SITAGLIPTIN/METFORMINMINT PHARMACEUTICALS INCTabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MGApproved
02544431NRA-SITAGLIPTINNORA PHARMA INCTabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 50 MGApproved
02544458NRA-SITAGLIPTINNORA PHARMA INCTabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 100 MGApproved
02544423NRA-SITAGLIPTINNORA PHARMA INCTabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 25 MGApproved
02536811REDDY-SITAGLIPTINDR REDDY'S LABORATORIES LTDTabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 50 MGApproved
02536838REDDY-SITAGLIPTINDR REDDY'S LABORATORIES LTDTabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 25 MGApproved
02540118REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDEDR REDDY'S LABORATORIES LTDTabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MGMarketed
02540134REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDEDR REDDY'S LABORATORIES LTDTabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MGMarketed
02540126REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDEDR REDDY'S LABORATORIES LTDTabletSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 50 MG; METFORMIN HYDROCHLORIDE 850 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
304352023-03-31Abbreviated New Drug Submission (ANDS)
Request a quote for REDDY-SITAGLIPTIN

How to read a Canadian DIN record